Validation of Antidiabetic and Antihyperlipidemic Effects of 80% Methanolic Extract of the Lonchocarpus laxiflorus Leaves in Streptozotocin-Induced Diabetic Swiss Albino Mice.
Getaye Tessema DestaYared Andargie FeredeWoretaw Sisay ZewduBaye Yrga AdugnaTilaye AregaMuluken Adela AlemuPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
was safe and possesses antidiabetic and antidyslipidemic activities.